» Articles » PMID: 36733684

Cardiac Sarcoidosis Presenting with Complex Conduction Abnormalities As the First Manifestation of Widespread Systemic Sarcoidosis: a Case Report

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Sarcoidosis is a granulomatous multi-organ disease of unknown aetiology. Despite being relatively rare, cardiac sarcoidosis constitutes a very important manifestation of sarcoidosis, as its symptoms regularly precede or occur in isolation of more prevalent ones, and as it is the main driver of mortality in systemic sarcoidosis.

Case Summary: We present the case of a 37-year-old woman, in which clinically isolated cardiac sarcoidosis revealed widespread systemic sarcoidosis. Apart from constitutional symptoms and strong recurrent dizziness (i.e. near-syncopes), which persisted for multiple years already, our patient initially presented with complex conduction abnormalities, including a right bundle branch block, left anterior hemi-block, and atrioventricular block °1. Following inconclusive endomyocardial biopsies, performed due to detection of focal septal scarring on cardiac magnetic resonance imaging, an F-FDG-PET-CT, performed upon admission to our clinic, showed distinct hypermetabolic lesions indicative of active inflammation in various organs and raised suspicion of systemic sarcoidosis. Eventually, histopathological evidence of non-caseating granulomas in affected lymph nodes, extracted by bronchoscopy, confirmed the diagnosis of systemic sarcoidosis after reasonable exclusion of other granulomatous diseases. Immediate initiation of long-term immunosuppressive therapy led to almost complete remission, as monitored by consequential F-FDG-PET-CT scans.

Discussion: Unexplained complex conduction abnormalities in young patients may be a sign of sarcoidosis, even in isolation of more prevalent symptoms. Correct interpretation and prompt initiation of a structured interdisciplinary diagnostic workup, including F-FDG-PET-CT as the imaging modality of choice, are essential to initiate specific treatment and obviate the major risk of mortality resulting from cardiac sarcoidosis.

References
1.
FLEMING H . Sarcoid heart disease. Br Heart J. 1974; 36(1):54-68. PMC: 1020012. DOI: 10.1136/hrt.36.1.54. View

2.
Iwai K, Tachibana T, Takemura T, Matsui Y, Kitaichi M, Kawabata Y . Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan. Acta Pathol Jpn. 1993; 43(7-8):372-6. DOI: 10.1111/j.1440-1827.1993.tb01148.x. View

3.
Chopra A, Kalkanis A, Judson M . Biomarkers in sarcoidosis. Expert Rev Clin Immunol. 2016; 12(11):1191-1208. DOI: 10.1080/1744666X.2016.1196135. View

4.
Hulten E, Agarwal V, Cahill M, Cole G, Vita T, Parrish S . Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Among Patients With Suspected Cardiac Sarcoidosis Is Associated With Adverse Cardiovascular Prognosis: A Systematic Review and Meta-Analysis. Circ Cardiovasc Imaging. 2016; 9(9):e005001. PMC: 5449111. DOI: 10.1161/CIRCIMAGING.116.005001. View

5.
Hunninghake G, Costabel U, Ando M, Baughman R, Cordier J, du Bois R . ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis. 1999; 16(2):149-73. View